CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in osteosarcoma patients. CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in osteosarcoma patients
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA646638
下载链接
链接失效反馈官方服务：
资源简介：
CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in osteosarcoma patients Overall design: Two-condition experiment, poor responder vs. good responder.
创建时间：
2020-07-16
